Thrombolytic Therapy
11
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
18%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk
Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital
Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: a Randomized Controlled Trial
Improving In-hospital Stroke Service Utilisation in China
Thromboelastometry and Ischemic Stroke (ThromboPredict)
Thrombolysis Outcome in Ischemic Stroke
Evaluation of the Effectiveness of Thrombolytic Therapy in Acute Ischemic Stroke Patients Using NIRS
Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke
Submassive Pulmonary Embolism Experience With EKOS